深静脈血栓症に関連した遺伝子変異
Irene D Bezemer1, Lance A Bare, Carine J M Doggen
1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
JAMA
|March 20, 2008
まとめ
この研究では,深静脈血栓症 (DVT) リスクに関連した主要な単一核性酸多形態 (SNPs) が特定されました. 遺伝的変異は,個人がDVTを発症する可能性に大きく影響します.
科学分野:
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
- エピデミオロジー エピデミオロジー
背景:
- 深静脈血栓症 (DVT) の遺伝的基盤は,まだ完全に解明されていません.
- 遺伝的危険因子を特定することは,DVTの病因と予防を理解するために極めて重要です.
研究 の 目的:
- DVTを発症するリスクの上昇に関連した特定の単核酸多形態 (SNP) を特定する.
- 血栓形成リスクに寄与する遺伝的構造を調査する.
主な方法:
- 何千人もの参加者を含む3つの大規模なケース・コントロール研究 (LETS,MEGA-1,MEGA-2) を利用しました.
- 19,000以上の遺伝子中心のSNPをゲノタイプし,オッズ比率を推定するためにロジスティック回帰分析を行った.
- 特定されたSNPの統計的有意性を厳格に評価するために,誤った発見率を適用しました.
主要な成果:
- DVTと強く関連している3つのSNPが特定されました:CYP4V2におけるrs13146272,SERPINC1におけるrs2227589,GP6.6におけるrs1613662.
- これらのSNPのリスクアレルあたりのDVTリスクの増加が観察され,オッズ比率は1.15~1.29.
- また,CYP4V2の近くにSNPが発見され,DVTと凝固因子XIのレベルとも関連している.
結論:
- 共通の遺伝的変異が,個人のDVTの感受性を決定する上で重要な役割を果たしていることを確認しました.
- 血栓形成リスクに寄与する特定の遺伝子とSNPを強調し,さらなる研究のための潜在的なターゲットを提供しました.
- CYP4V2領域,DVT,および因子XIレベルにおける遺伝的変異との関連が示された.
関連する概念動画
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Varicose Veins I: Introduction
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...


